Surviving Cutaneous Melanoma

A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

Amy A. Mrazek, Celia Chao

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

Original languageEnglish (US)
Pages (from-to)989-1002
Number of pages14
JournalSurgical Clinics of North America
Volume94
Issue number5
DOIs
StatePublished - Oct 1 2014

Fingerprint

Practice Management
Melanoma
Recurrence
Skin
Survivors
Neoplasms
Survival Rate
Guidelines
Neoplasm Metastasis
Phenotype
Mortality

Keywords

  • Management of recurrence
  • Melanoma survivorship
  • Surveillance and follow-up
  • Survival prognosis

ASJC Scopus subject areas

  • Surgery

Cite this

Surviving Cutaneous Melanoma : A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence. / Mrazek, Amy A.; Chao, Celia.

In: Surgical Clinics of North America, Vol. 94, No. 5, 01.10.2014, p. 989-1002.

Research output: Contribution to journalArticle

@article{607448ff52f44bc0887f0670c90608ec,
title = "Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence",
abstract = "The number of melanoma survivors in the United States continues to steadily increase 2.6{\%} per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.",
keywords = "Management of recurrence, Melanoma survivorship, Surveillance and follow-up, Survival prognosis",
author = "Mrazek, {Amy A.} and Celia Chao",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.suc.2014.07.003",
language = "English (US)",
volume = "94",
pages = "989--1002",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Surviving Cutaneous Melanoma

T2 - A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

AU - Mrazek, Amy A.

AU - Chao, Celia

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

AB - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

KW - Management of recurrence

KW - Melanoma survivorship

KW - Surveillance and follow-up

KW - Survival prognosis

UR - http://www.scopus.com/inward/record.url?scp=84907624135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907624135&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2014.07.003

DO - 10.1016/j.suc.2014.07.003

M3 - Article

VL - 94

SP - 989

EP - 1002

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 5

ER -